X

Health Care

MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024.…

Alumis looks to raise $300 million in IPO. Here’s what you need to know

Technology and healthcare companies are continuing to dominate the IPO market, which is witnessing a significant increase in activity compared…

WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable…

Tempus AI gears up for IPO. Here’s everything you need to know

The IPO market witnessed stronger activity so far this year compared to the corresponding period last year, with a marked…

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a new-generation biotechnology firm that works to accelerate the development of new therapies by…

Key metrics from Medtronic’s (MDT) Q4 2024 earnings results

Medtronic plc (NYSE: MDT) reported fourth quarter 2024 earnings results today. Worldwide revenue was $8.6 billion, up 0.5% on a…

Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company…

Earnings Summary: Organon reports financial results for Q1 2024

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024.…

Cigna Group (CI) reports double-digit revenue growth for Q1; guides FY24

The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, Thursday reported a sharp increase in…

Infographic: A snapshot of Moderna’s (MRNA) Q1 2024 earnings results

Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company's revenues declined…